Literature DB >> 12464100

Transient total sleep loss in cerebral Whipple's disease: a longitudinal study.

Ulrich Voderholzer1, Dieter Riemann, Horst Gann, Magdolna Hornyak, Freimut Juengling, Martin Schumacher, Martin Reincke, Axel Von Herbay, Seiji Nishino, Emmanuel Mignot, Mathias Berger, Klaus Lieb.   

Abstract

A case with transient, almost complete sleep loss caused by cerebral manifestation of Whipple's disease (WD) is presented. Cerebral WD is rare and in most cases occurs after gastrointestinal infection. In our case, a progressive and finally almost complete sleep loss was the initial and predominant symptom. Polysomnographic studies in several consecutive nights and over 24 h showed a total abolition of the sleep-wake cycle with nocturnal sleep duration of less than 15 min. Endocrine tests revealed hypothalamic dysfunction with flattening of circadian rhythmicity of cortisol, TSH, growth hormone and melatonin. Cerebrospinal fluid (CSF) hypocretin was reduced. [18F]Deoxyglucose positron emission tomography (FDG-PET) revealed hypermetabolic areas in cortical and subcortical areas including the brainstem, which might explain sleep pathology and vertical gaze palsy. In the course of treatment with antibiotics and additional carbamazepine for 1 year, insomnia slowly and gradually improved. Endocrine investigations at 1-year follow-up showed persistent flattening of circadian rhythmicity. The FDG-PET indicated normalized metabolism in distinct regions of the brain stem which paralleled restoration of sleep length. The extent of sleep disruption in this case of organic insomnia was similar to cases of familial fatal insomnia, but was at least partially reversible with treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464100     DOI: 10.1046/j.1365-2869.2002.00311.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  4 in total

1.  Whipple's disease masquerades as dementia with Lewy bodies.

Authors:  Kyle Hurth; Rawan Tarawneh; Nupur Ghoshal; Tammie L S Benzinger; David B Clifford; Michael Geschwind; John C Morris; James E Galvin; Robert E Schmidt; Nigel J Cairns
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

2.  Neurologic manifestations of Whipple's disease.

Authors:  Mara M Lugassy; Elan D Louis
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 3.  Hypersomnia.

Authors:  Yves Dauvilliers; Alain Buguet
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

4.  Central Nervous System Whipple Disease Presenting as Hypersomnolence.

Authors:  Marcela A de Oliveira Santana; Saira Butt; Mehdi Nassiri
Journal:  Cureus       Date:  2022-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.